Trial intelligence / Profile preview

Hepatitis A Vaccination in RA Patients on TNF-inhibitors/Mtx

NCT01360970Phase 2Completed

Start
Sep 2009
Primary completion
May 2011
Modality
Whole Inactivated Vaccines
Countries
2
01

Overview

A Phase 2 trial of Hepatitis A virus vaccine, Epaxal Junior in hepatitis A (HAV). Started Sep 2009; status: completed.

02

Drugs

Hepatitis A virus vaccineEpaxal Junior
03

Conditions

hepatitis A (HAV)

Beyond the preview

Go deeper on NCT01360970.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01360970.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call